Trials / Completed
CompletedNCT05821712
A New Mouthwash on Reducing Dental Plaque and Helping Prevent Gum Problems
Investigation of Clinical Efficacy of a New Mouthwash on Reducing Dental Plaque and Helping Prevent Gum Problems as Compared to a Control Mouthwash - a Six-month Study in Italy
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 80 (actual)
- Sponsor
- Colgate Palmolive · Industry
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Accepted
Summary
This 6-month clinical study was designed to investigate clinical efficacy on plaque and gingivitis for the Meridol Base Mouthwash containing 0.2% zinc lactate, 0.17% amine fluoride and 0.0275% sodium fluoride as compared to a Negative Control Mouthwash containing 0.057% sodium fluoride after 3 and 6 months of product use.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | 0.2% zinc lactate, 0.17% amine fluoride and 0.0275% sodium fluoride Mouthwash | mouthwash |
| DRUG | 0.057% sodium fluoride Mouthwash | mouthwash |
Timeline
- Start date
- 2021-03-08
- Primary completion
- 2021-09-24
- Completion
- 2021-09-24
- First posted
- 2023-04-20
- Last updated
- 2023-04-20
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT05821712. Inclusion in this directory is not an endorsement.